About This Test
Liver disease is a serious and potentially life-threatening condition that affects millions of people worldwide. One important tool in the diagnosis and treatment of liver disease is the Hepatitis Panel - Acute Screen-II (HAV-IgM, Anti HBc ? IgM, HBsAg, HCV-Antibody, HEV - IgM) test. This test is recommended by Ampath Lab, Hyderabad because it can help doctors identify the specific type of hepatitis virus causing the disease, as well as determine the severity of the infection. By keeping track of important health markers like these, patients can stay informed about their health and take proactive steps to prevent liver disease from progressing. With the Hepatitis Panel - Acute Screen-II (HAV-IgM, Anti HBc ? IgM, HBsAg, HCV-Antibody, HEV - IgM) test, early detection and treatment of liver disease is more effective than ever.